Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Virpax Pharmaceuticals
(NASDAQ:VRPX)
Intraday
$2.60
0.11
[4.42%]
After-Hours
$2.60
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.60
0.11
[4.42%]
At close: May 10
$2.60
0
[0.00%]
After Hours: 4:26PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Virpax Pharmaceuticals Stock (NASDAQ:VRPX)
Virpax Pharmaceuticals Stock (NASDAQ: VRPX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 30, 2024
Virpax Pharmaceuticals Announced Results For A Maximum Tolerated Dose Study In Sprague-dawley Rats For Probudur
Benzinga Newsdesk
-
Apr 30, 2024, 7:39AM
Thursday, April 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Apr 18, 2024, 4:31PM
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 8, 2024, 8:09AM
Wednesday, April 03, 2024
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
Benzinga Newsdesk
-
Apr 3, 2024, 4:28PM
Tuesday, March 26, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 26, 2024, 5:32PM
Virpax Pharma Reported FY23 EPS Loss of $(12.97) Vs $(9.20) Est, Cash Balance of $9.1M
Benzinga Newsdesk
-
Mar 26, 2024, 7:33AM
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 19, 2024, 5:34PM
Monday, March 18, 2024
Virpax Pharmaceuticals SaidOn March 15, Got Letter From Nasdaq That Co Has Regained Compliance With Listing Rule 5550(A)(2)
Charles Gross
-
Mar 18, 2024, 6:38AM
Thursday, February 29, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Feb 29, 2024, 7:50PM
Tuesday, February 27, 2024
Virpax Pharmaceuticals shares are trading lower after the company announced a proposed settlement of litigation with Sorrento Therapeutics and Scilex Pharmaceuticals. Also, the company announced a 1-for-10 reverse stock split.
Benzinga Newsdesk
-
Feb 27, 2024, 12:24PM
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics And Scilex Pharmaceuticals
Benzinga Newsdesk
-
Feb 27, 2024, 7:43AM
Virpax Pharmaceuticals Announces 1-For-10 Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price, Effective March 1, 2024
Benzinga Newsdesk
-
Feb 27, 2024, 7:33AM
Wednesday, February 21, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 21, 2024, 4:31PM
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 19, 2024, 4:30PM
Friday, February 16, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 16, 2024, 4:31PM
Wednesday, February 07, 2024
Virpax Pharmaceuticals Announced The Initial Results From The Pilot Study For Probudur Performed By The U.S. Army Institute Of Surgical Research Under An Existing Cooperative Research And Development Agreement
Benzinga Newsdesk
-
Feb 7, 2024, 7:39AM
Wednesday, January 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jan 17, 2024, 4:31PM
Friday, December 29, 2023
Virpax Pharmaceuticals Says It Will Announce Reverse Stock Split Ratio Between 1-To-2 To 1-To-20, The Anticipated Effective Date To Be Disclosed At Later Time
Benzinga Newsdesk
-
Dec 29, 2023, 7:36AM
Friday, December 15, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Dec 15, 2023, 4:31PM
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 15, 2023, 12:46PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 15, 2023, 12:31PM
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 15, 2023, 8:17AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 15, 2023, 8:08AM
Thursday, December 14, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 14, 2023, 4:31PM
Tuesday, December 05, 2023
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Dec 5, 2023, 1:06PM
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Dec 5, 2023, 9:04AM
Monday, December 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 4, 2023, 4:31PM
Friday, November 17, 2023
Virpax Pharmaceuticals Appoints Gerald Bruce As CEO And Eric Floyd As Chairman
Benzinga Newsdesk
-
Nov 17, 2023, 7:04AM
Wednesday, November 15, 2023
Virpax Pharmaceuticals Q3 2023 EPS $(0.51) Up From $(0.65) YoY
Benzinga Newsdesk
-
Nov 15, 2023, 4:36PM
Tuesday, October 31, 2023
Virpax Pharmaceuticals Announces That Envelta Remains On Track For Trial In Humans Following FDA Review
Benzinga Newsdesk
-
Oct 31, 2023, 8:59AM
Friday, October 27, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 27, 2023, 5:31PM
Tuesday, October 17, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Oct 17, 2023, 5:31PM
Thursday, October 12, 2023
Virpax Pharmaceuticals Announces Extension Of Cooperative Research And Development Agreement With US Army Institute Of Surgical Research
Bill Haddad
-
Oct 12, 2023, 8:08AM
Wednesday, October 11, 2023
Virpax Pharmaceuticals On Oct 10 Got Written Notification From Nasdaq Granting Co's Request For 180-Day Extension To Regain Compliance
Benzinga Newsdesk
-
Oct 11, 2023, 4:14PM
Wednesday, September 27, 2023
Virpax Pharmaceuticals Announces Results Of Probudur Dose Escalation Studies
Benzinga Newsdesk
-
Sep 27, 2023, 9:02AM
Thursday, September 21, 2023
Altasciences Chosen By Virpax To Support The Development Of A New Drug To Prevent Spread Of Flu-Like Viruses
Benzinga Newsdesk
-
Sep 21, 2023, 10:01AM
Monday, September 18, 2023
Virpax Pharmaceuticals Has Formed A New Wholly-owned Subsidiary, Novvae Pharmaceuticals, Which Has Been Established To Focus Exclusively On Advancing Virpax's OTC Pipeline
Benzinga Newsdesk
-
Sep 18, 2023, 7:59AM
Monday, September 11, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Sep 11, 2023, 5:31PM
Tuesday, September 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Sep 5, 2023, 5:31PM
Monday, September 04, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Sep 4, 2023, 9:05AM
Friday, September 01, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Sep 1, 2023, 9:06AM
Thursday, August 31, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Aug 31, 2023, 5:31PM
Thursday, August 17, 2023
Chief Financial Officer at Virpax Pharmaceuticals Acquires Company Stock Options Worth 100,000 Shares
Benzinga Insights
-
Aug 17, 2023, 11:01AM
Monday, August 14, 2023
Virpax Pharmaceuticals Q2 EPS $(0.27) Up From $(0.50) YoY
Happy Mohamed
-
Aug 14, 2023, 9:16AM
Thursday, August 10, 2023
Virpax Pharmaceuticals Files Provisional Patent Application For NSAID Formulation And Method
Happy Mohamed
-
Aug 10, 2023, 8:59AM
Wednesday, August 09, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Aug 9, 2023, 5:32PM
Monday, July 24, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jul 24, 2023, 9:06AM
Friday, July 21, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Jul 21, 2023, 5:32PM
Thursday, July 13, 2023
Virpax Pharmaceuticals Files Provisional Patent Application For Intranasal Delivery
Benzinga Newsdesk
-
Jul 13, 2023, 8:59AM
Wednesday, June 21, 2023
Virpax Pharmaceuticals Enters Into Cooperative Research And Development Agreement With The National Advisory Neurological Disorders And Stroke Council
Happy Mohamed
-
Jun 21, 2023, 8:14AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch